ストックスクリーナーアプリを入手
123.16
1.00%
-1.24
プレマーケット:
124.02
0.86
+0.70%
Biogen Inc (BIIB) 最新ニュース
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Hudson Bay Capital Management LP - MarketBeat
Gotham Asset Management LLC Buys 47,182 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Why Biogen Inc. (BIIB) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom - Yahoo Finance
Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance
Biogen Completes $1.75 Billion Notes Issuance - TipRanks
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now - Insider Monkey
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know - Yahoo Finance
Deutsche Bank AG Purchases 455,285 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Rep. Robert Bresnahan, Jr. Sells Biogen Inc. (NASDAQ:BIIB) Stock - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Sold by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Bokf Na Trims Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Comerica Bank - MarketBeat
Cognitive Impairment Associated with Schizophrenia Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Cyclerion Therapeutics, Biogen, Neurocrine - Barchart.com
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Stifel Financial Corp - MarketBeat
Biogen Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights – BIIB - ACCESS Newswire
Brevan Howard Capital Management LP Boosts Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Brown Advisory Inc. Acquires 14,339 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
BIIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - ACCESS Newswire
UPCOMING BIIB DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Axa S.A. Buys 103,677 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
IMMINENT BIIB DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Spinal Muscular Atrophy Market Advances with Gene Therapies and Rare Disease Research | Novartis, Biogen, Roche - openPR.com
South San Francisco to Host Biogen’s New West Coast Operations - whatnow.com
Navigating the Trump tariffs, part two: Amgen, Biogen, others - BioWorld MedTech
Mizuho Has Lowered Expectations for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat
Biogen Says Its US Manufacturing Will Limit Tariff Impacts - MSN
BIOGEN INC. (NASDAQ:BIIB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc. (NASDAQ: BIIB) - ACCESS Newswire
Leerink Partnrs Has Positive Outlook of Biogen Q3 Earnings - MarketBeat
Analysts Set Biogen Inc. (NASDAQ:BIIB) Price Target at $195.85 - MarketBeat
Wedbush Predicts Biogen's Q4 Earnings (NASDAQ:BIIB) - MarketBeat
Gene Giant Biogen to Open West Coast Hub in South SF - The Real Deal
Digital Biomarkers Market Hits New High | Major Giants Biogen, Apple, Alphabet, Evidation Health, Koneksa - openPR.com
Medisafe PATHWAYS, Eisai and Biogen Recognized for - GlobeNewswire
Medisafe PATHWAYS, Eisai and Biogen Recognized for Alzheimer’s Disease Innovation in 2025 MedTech Breakthrough Awards Program - GlobeNewswire Inc.
Form 424B2 BIOGEN INC. - StreetInsider
Biogen (NASDAQ:BIIB) Announces Quarterly Earnings Results, Misses Expectations By $0.24 EPS - MarketBeat
Northern Trust Corp Grows Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen, Inc.Steady as She Goes as the Ship Continues to Turn Slowly - Smartkarma
After big acquisition, Biogen looks to set up West Coast hub in South San Francisco - The Business Journals
Biogen (NasdaqGS:BIIB) Selects Multiple Co-Lead Underwriters for US$1 Billion Fixed-Income Offering - simplywall.st
Biogen (NASDAQ:BIIB) Price Target Lowered to $175.00 at JPMorgan Chase & Co. - MarketBeat
Biogen (BIIB) Price Target Lowered by Mizuho Despite Outperform Rating | BIIB Stock News - GuruFocus
Biogen (BIIB) Prepares for Mid-2026 Readout of Key Program | BIIB Stock News - GuruFocus
Biogen (BIIB) Receives Price Target Reduction from Mizuho | BIIB Stock News - GuruFocus
Integrated Wealth Concepts LLC Grows Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
AQR Capital Management LLC Purchases 489,811 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
FY2025 Earnings Estimate for Biogen Issued By William Blair - MarketBeat
Lido Advisors LLC Acquires 39,910 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Schonfeld Strategic Advisors LLC Increases Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen (BIIB): JP Morgan Lowers Price Target But Maintains Neutral Rating | BIIB Stock News - GuruFocus
Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Biogen Inc, BioXcel Corp, Celavie Biosciences, Ionis Pharma - Barchart.com
Spinocerebellar Ataxias Pipeline 2025: Comprehensive - openPR.com
JPMorgan Adjusts Price Target for Biogen (BIIB) Following Q1 Report | BIIB Stock News - GuruFocus
Oligonucleotide Delivery System Market Key Players Analysis - openPR.com
Red Biotechnology Market to Witness Remarkable Growth with - openPR.com
2.30%
大文字化:
|
ボリューム (24 時間):